As of 2026-04-02, 中美天津史克制药's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 10.7 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 中美天津史克制药's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
中美天津史克制药's Mention Rate is 0.00%, lower than 0.6% of competitors
中美天津史克制药's First Mention is 0.00%, lower than 0.9% of competitors
中美天津史克制药's Preferred Rate is 0.00%, lower than 100.0% of competitors
中美天津史克制药's Positive Rate is 0.00%, lower than 8.9% of competitors
中美天津史克制药's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 68.85% | 21.31% | 36.84% | 63.93% | 6.56% | View Details |
| 礼礼来 | 52.46% | 39.34% | 42.11% | 49.18% | 0% | View Details |
| 罗罗氏 | 39.34% | 1.64% | 5.26% | 34.43% | 0% | View Details |
| 石石药集团 | 34.43% | 0% | 0% | 24.59% | 1.64% | View Details |
| 强强生 | 32.79% | 8.2% | 0% | 27.87% | 0% | View Details |
| 艾艾伯维 | 32.79% | 0% | 0% | 31.15% | 1.64% | View Details |
| 中中美天津史克制药 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
